CLINICAL TRIAL collaboration AGREEMENTClinical Trial Collaboration Agreement • September 9th, 2014 • Advaxis, Inc. • Pharmaceutical preparations • Delaware
Fifth Amendment to Amended and Restated License AgreementLicense Agreement • September 9th, 2014 • Advaxis, Inc. • Pharmaceutical preparations
This Fifth Amendment (the “Fifth Amendment”) is made and entered into as of July 25, 2014 (the “Effective Date”) by and between The Trustees of the University of Pennsylvania (“Penn”) and Advaxis, Inc., a corporation organized and existing under the laws of Delaware (“Company”) having a place of business at 305 College Road East, Princeton, New Jersey 08540, amends the Amended and Restated License Agreement dated February 13, 2007, as amended by the First Amendment to the License Agreement dated March 26, 2007, the Second Amendment to the License Agreement dated May 10,2010, the Third Amendment to the License Agreement dated December 12, 2011 and the Fourth Amendment to the License Agreement dated May 14, 2013 (the “License Agreement”).
